<?xml version="1.0" encoding="UTF-8"?>
<p>A new series of geldanamycin (GA) derivatives have been synthesized which were evaluated as antiviral compounds against HCV in GS4.3 HCV replicon cells. Many of these synthesized compounds exhibited competitive anti-HCV activity [
 <xref ref-type="bibr" rid="B50">50</xref>].
</p>
